Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 7 - Jul 12
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Holisan Deparayur 90tbHolisan Deparayur Kruidenpreparaat Samenstelling per dagdosering (4 tabletten): Zwarte myrobalaan (Terminalia chebula) 208 mg Trichosanthes dioica 208 mg Murraya koenigii 60 mg Gember (Zingiber officinale) 20 mg Ingredienten Zwarte myrobalaan Trichosantes dioica Murraya koenigii gember Arabische gom Gebruik 3 tot 4 maal daags 1 tablet na de maaltijd innemen. Fabrikant: Holisan BV Postbus 242 8200 AE Lelystad Dit product is een voedingssupplement.
Holisan Deparayur
Kruidenpreparaat
Samenstelling per dagdosering (4 tabletten):
| Zwarte myrobalaan (Terminalia chebula) | 208 mg |
| Trichosanthes dioica | 208 mg |
| Murraya koenigii | 60 mg |
| Gember (Zingiber officinale) | 20 mg |
Ingredienten
Zwarte myrobalaan Trichosantes dioica Murraya koenigii gember Arabische gom
Gebruik
3 tot 4 maal daags 1 tablet na de maaltijd innemen.
Fabrikant:
Holisan BV
Postbus 242
8200 AE Lelystad
Dit product is een voedingssupplement.
Aanbevolen dosering niet overschrijden.
Een gevarieerde evenwichtige voeding en een gezonde levensstijl zijn belangrijk. Een voedingssupplement is geen vervanging van een gevarieerde voeding.
Buiten bereik van jonge kinderen houden.
Droog afgesloten en bij kamertemperatuur bewaren tenzij anders geadviseerd op het etiket.
Raadpleeg een deskundige alvorens supplementen te gebruiken in geval van zwangerschap lactatie medicijngebruik en ziekte.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.4 ★★★★★
Based on 1777 reviews
Sort
Product Reviews
★★★★★ 4
good start
Format: Kindle
Good start been a while since we see Peter do a mystery investigation hopefully Peter can keep this job. Love the art by Pepe Larraz hopefully he sticks around for a long time
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2025
★★★★★ 5
Really good!
Format: Kindle
Great comic! Good continuation of the series before and art style is really good! Gives you a good view into the struggle of Peter As he tries to actually live life with being Spider-Man as well
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 13, 2025
★★★★★ 5
Amazing!
Format: Kindle
Really good start! I am liking this series a lot. Will be here for future issues! Read it today! Its very good.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 11, 2025
★★★★★ 5
Very good
Format: Kindle
So good my favorite series of 2025! Can't wait to read more. Better not being with MJ is different but shay is pretty cool.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 17, 2025
★★★★★ 2
An immature take on Peter Parker only suitable for the most immature reader
Format: Kindle
Someday, Marvel Comics won't be controlled by white male Boomers/GenXers who make Peter Pan look well adjusted and who incessantly try to recapture a childhood that never actually existed while believing women have cooties and adult relationships are icky. But until then, we get Amazing Spider-Man by Joe Kelly, whose writing is the living embodiment of the Steve Buscemi "How do you do, my fellow kids" meme.
This run is boring, trite and cliched. You could probably get a more insightful and original story by asking ChatGPT to write one for you. The only thing going for the run - so far - is that Kelly at least isn't outright aggressively antagonizing the reader unlike the previous writer. It's just...bland and mediocre.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 21, 2025